Objective: Urinary incontinence (UI) is one of the most common urinary system diseases that mostly affects women but also men. We evaluated the therapeutic efficacy of functional magnetic stimulation (FMS) as potential UI treatment with improvements in the pelvic floor musculature, urodynamic tests and quality of life. Methods: A total of 20 UI patients (10 females and 10 men, mean age 64, 14 years), including 10 with stress UI, four with urgency UI and six with mixed UI, were treated with FMS (20 min/session) twice a week for 3 weeks. The patients’ impressions, records in urinary diaries, and scores of three life stress questionnaires (overactive bladder symptom questionnaire [OAB-q], urogenital distress inventory questionnaire-short form [UDI-6], incontinence impact questionnaire-short form [IIQ-7]) were performed pre- and post-treatment. Results: Significant reductions (P < 0.01) of micturition number and nocturia after magnetic treatment were evi- denced. The urodynamic tests recorded a significant increase in cystometric capacity (147 ± 51.3%), in maximum urethral closure pressure (110 ± 34%), in urethral functional length (99.8 ± 51.8%), and in pressure transmission ratio (147 ± 51.3%) values compared with the baseline values. Conclusions: These preliminary findings suggest that FMS with Magneto STYM (twice weekly for 3 weeks) improves the UI and may be an effective treatment for this urogenital disease.

High-power Magnetotherapy: A New Weapon in Urinary Incontinence? / Vadala', Maria; Palmieri, Beniamino; Malagoli, Andrea; Laurino, Carmen. - In: LUTS. - ISSN 1757-5664. - 10:3(2018), pp. 266-270. [10.1111/luts.12174]

High-power Magnetotherapy: A New Weapon in Urinary Incontinence?

VADALA', MARIA;Palmieri Beniamino;Malagoli Andrea;Laurino Carmen
2018

Abstract

Objective: Urinary incontinence (UI) is one of the most common urinary system diseases that mostly affects women but also men. We evaluated the therapeutic efficacy of functional magnetic stimulation (FMS) as potential UI treatment with improvements in the pelvic floor musculature, urodynamic tests and quality of life. Methods: A total of 20 UI patients (10 females and 10 men, mean age 64, 14 years), including 10 with stress UI, four with urgency UI and six with mixed UI, were treated with FMS (20 min/session) twice a week for 3 weeks. The patients’ impressions, records in urinary diaries, and scores of three life stress questionnaires (overactive bladder symptom questionnaire [OAB-q], urogenital distress inventory questionnaire-short form [UDI-6], incontinence impact questionnaire-short form [IIQ-7]) were performed pre- and post-treatment. Results: Significant reductions (P < 0.01) of micturition number and nocturia after magnetic treatment were evi- denced. The urodynamic tests recorded a significant increase in cystometric capacity (147 ± 51.3%), in maximum urethral closure pressure (110 ± 34%), in urethral functional length (99.8 ± 51.8%), and in pressure transmission ratio (147 ± 51.3%) values compared with the baseline values. Conclusions: These preliminary findings suggest that FMS with Magneto STYM (twice weekly for 3 weeks) improves the UI and may be an effective treatment for this urogenital disease.
18-giu-2017
10
3
266
270
High-power Magnetotherapy: A New Weapon in Urinary Incontinence? / Vadala', Maria; Palmieri, Beniamino; Malagoli, Andrea; Laurino, Carmen. - In: LUTS. - ISSN 1757-5664. - 10:3(2018), pp. 266-270. [10.1111/luts.12174]
Vadala', Maria; Palmieri, Beniamino; Malagoli, Andrea; Laurino, Carmen
File in questo prodotto:
File Dimensione Formato  
VADAL-_et_al-2018-LUTS%3A_Lower_Urinary_Tract_Symptoms.pdf

accesso aperto

Tipologia: Versione dell'editore (versione pubblicata)
Dimensione 316.36 kB
Formato Adobe PDF
316.36 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11380/1168027
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 9
social impact